THE SIRTUIN 6 ATTENUATES MYOCARDIAL INJURY AND DYSFUNCTION BY REGULATING ADAM17/ACE2 PATHWAY IN HYPERTENSIVE RATS

被引：0
|
作者：
Cheng, Yu-Wen [1 ]
Xu, Ying-Le [1 ]
Zhang, Zhen-Zhou [1 ]
Wang, Juan [2 ,3 ]
Liu, Xiao-Yan [2 ,3 ]
Li, Jing [2 ,3 ]
Fan, Yi-Fan [2 ,3 ]
Yang, Mei [2 ,3 ]
Yang, Xin-Chun [2 ,3 ]
Zhong, Jiu-Chang [2 ,3 ]
机构：
[1] Shanghai Jiao Tong Univ, Sch Med China, Hypertens Ruijin Hosp, Shanghai Inst, Shanghai, Peoples R China
[2] Capital Med Univ China, Heart Ctr, Beijing Chaoyang Hosp, Beijing, Peoples R China
[3] Capital Med Univ China, Beijing Key Lab Hypertens, Beijing Chaoyang Hosp, Beijing, Peoples R China
来源：
JOURNAL OF HYPERTENSION | 2018年 / 36卷
关键词：
SIRT6; fibrosi s; myocardial injury; ACE2; hypertension;
D O I：
10.1097/01.hjh.0000548274.70902.b3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
A12686
引用
收藏
页码：E70 / E70
页数：1
相关论文
共 50 条
  • [21] ACE2 activator attenuates upregulation of MIF in left ventricular dysfunction in myocardial infarcted rat
    YAO Qing-zhou
    中国病理生理杂志, 2012, (11) : 2026 - 2026
  • [22] The collectrin-like part of the SARS-CoV-1 and-2 receptor ACE2 is shed by the metalloproteinases ADAM10 and ADAM17
    Niehues, Rabea Victoria
    Wozniak, Justyna
    Wiersch, Florian
    Lilienthal, Eva
    Tacken, Nikola
    Schumertl, Tim
    Garbers, Christoph
    Ludwig, Andreas
    Duesterhoeft, Stefan
    FASEB JOURNAL, 2022, 36 (03):
  • [23] Angiotensin-II promotes ACE2 shedding by increasing ADAM17 expression and oxidative stress in Neuro2A cells
    de Queiroz, Thyago Moreira
    Sriramula, Srinivas
    Chaudhari, Anju
    Filipeanu, Catalin
    Lazartigues, Eric
    FASEB JOURNAL, 2014, 28 (01):
  • [24] Pulmonary, cardiac and renal distribution of ACE2, furin, TMPRSS2 and ADAM17 in rats with heart failure: Potential implication for COVID-19 disease
    Khoury, Emad E.
    Knaney, Yara
    Fokra, Ahmad
    Kinaneh, Safa
    Azzam, Zaher
    Heyman, Samuel N.
    Abassi, Zaid
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (08) : 3840 - 3855
  • [25] Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression
    Zhong, Jiu-Chang
    Ye, Jia-ying
    Jin, Hai-yan
    Yu, Xi
    Yu, Hui-min
    Zhu, Ding-liang
    Gao, Ping-jin
    Huang, Dong-yang
    Shuster, Manfred
    Loibner, Hans
    Guo, Jun-min
    Yu, Xi-yong
    Xiao, Bing-xiu
    Gong, Zhao-hui
    Penninger, Josef M.
    Oudit, Gavin Y.
    REGULATORY PEPTIDES, 2011, 166 (1-3) : 90 - 97
  • [26] Stimulation of the ACE2/Ang-(1–7)/Mas axis in hypertensive pregnant rats attenuates cardiovascular dysfunction in adult male offspring
    Amanda S. M. Bessa
    Érika F. Jesus
    Allancer D. C. Nunes
    Carolina N. R. Pontes
    Ismaley S. Lacerda
    Jaqueline M. Costa
    Elisângela J. Souza
    Ruy S. Lino-Júnior
    Manoel F. Biancardi
    Fernanda C. A. dos Santos
    Gustavo R. Pedrino
    Diego B. Colugnati
    Renata Mazaro-Costa
    Elizabeth P. Mendes
    Carlos H. Castro
    Hypertension Research, 2019, 42 : 1883 - 1893
  • [27] How tetraspanin-mediated cell entry of SARS-CoV-2 can dysregulate the shedding of the ACE2 receptor by ADAM17
    Healy, Eamonn F.
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2022, 593 : 52 - 56
  • [28] Increased ADAM17 Expression in ACE2 Knockout Mice is Associated with Increased Excitability of Paraventricular Nucleus Pre-sympathetic Neurons
    Mukerjee, Snigdha
    Sriramula, Srinivas
    Zsombok, Andrea
    Lazartigues, Eric
    FASEB JOURNAL, 2015, 29
  • [29] GTS-21 attenuates ACE/ACE2 ratio and glycocalyx shedding in lipopolysaccharide-induced acute lung injury by targeting macrophage polarization derived ADAM-17
    Zhu, Weiwei
    Wang, Fengyun
    Hu, Chang
    Zhao, Qiuyue
    Zhang, Dandan
    Wang, Xiaozhi
    Hu, Bo
    Li, Jianguo
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 129
  • [30] Protective effect of diminazene attenuates myocardial infarction in rats via increased inflammation and ACE2 activity
    Chen, Junjiang
    Cui, Lianqun
    Yuan, Jingliang
    Zhang, Songcun
    Ma, Rongmei
    Sang, Hongjun
    Liu, Qingjiang
    Shan, Lianfeng
    MOLECULAR MEDICINE REPORTS, 2017, 16 (04) : 4791 - 4796
12345